Otsuka, NCC Develop Comprehensive Genomic Profiling Assay for Blood Cancer

March 27, 2020
Koji Izutsu (left), Head, Hematology Department, NCC Hospital, and Keisuke Kataoka, Chief, Division of Molecular Oncology, NCC, at Tokyo Press Conference Otsuka Pharmaceutical and the National Cancer Center said on March 26 that they have jointly developed what they claim...read more